Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004838013 | SCV005462414 | uncertain significance | not specified | 2024-11-24 | criteria provided, single submitter | clinical testing | The c.1637A>T (p.Y546F) alteration is located in exon 3 (coding exon 3) of the NPC1L1 gene. This alteration results from a A to T substitution at nucleotide position 1637, causing the tyrosine (Y) at amino acid position 546 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |